Related Experiment Videos
Bronchiectasis in bone marrow transplantation
1Division of Pulmonary Medicine, Veterans Affairs Medical Center, Lexington, Kentucky, USA.
Thorax
|April 1, 1997
Summary
Bronchiectasis, a lung condition, may be an under-recognized complication of chronic graft-versus-host disease following bone marrow transplants for blood cancers. Treatment with corticosteroids showed some clinical improvement in patients.
Area of Science:
- Pulmonology
- Hematology
- Immunology
Background:
- Allogeneic bone marrow transplantation is a curative therapy for hematological malignancies.
- Graft-versus-host disease (GVHD) is a common complication following allogeneic bone marrow transplantation.
- Chronic GVHD can affect multiple organs, leading to long-term complications.
Observation:
- Two patients developed clinical and radiographic bronchiectasis after allogeneic bone marrow transplantation.
- Both patients exhibited signs of chronic GVHD in organs other than the lungs.
- Persistent mucopurulent sputum production and progressive airflow obstruction were noted in the patients.
Findings:
- Bronchiectasis, characterized by persistent lung damage, was observed in patients with chronic GVHD.
- Increased immunosuppression using corticosteroids led to a clinical response in the affected patients.
- Despite treatment, chronic sputum production and airflow obstruction persisted in one patient.
Implications:
- Bronchiectasis may be an under-recognized pulmonary manifestation of chronic GVHD.
- Early recognition and management of pulmonary GVHD are crucial for improving patient outcomes.
- Further research is needed to elucidate the pathogenesis and optimal treatment strategies for bronchiectasis in the context of chronic GVHD.